Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

Does Partial Indomethacin Relief Mean Hemicrania Continua?

At a Glance

Partial relief from indomethacin does not by itself confirm or rule out hemicrania continua. A clinician must review whether the dose, duration, and adherence were adequate, reassess other causes, and choose safe next steps without self-increasing the dose.

Bottom Line: A partial response to indomethacin neither confirms nor rules out hemicrania continua. It may simply reflect a general pain-relieving effect. Do not change your dose without a doctor’s guidance. Seek emergency care if you experience a sudden “worst-ever” headache, new weakness, confusion, vision loss, a painful red eye, fever with neck stiffness, or if your headache follows a head injury.

The standard medical criteria for diagnosing hemicrania continua require an “absolute” or complete elimination of headache pain when taking a therapeutic dose of indomethacin [1][2]. Therefore, experiencing only partial relief does not meet the formal requirements to confirm the diagnosis. Partial improvement may reflect a non-specific pain-relief effect rather than proving you have the condition. However, it also does not completely rule out hemicrania continua if the medication trial was inadequate. It means you and your doctor must carefully review your trial, reconsider the diagnosis, and discuss next steps.

Reviewing the Indomethacin Trial

Before finalizing a diagnosis, your doctor will likely want to review the specifics of your indomethacin trial. What constitutes an “adequate” trial depends on your individual health factors, but several elements can make a response appear incomplete:

  • Dose and Duration: The dose and time required to achieve complete relief vary significantly from person to person [3][4]. A trial is individualized and must be supervised based on your age, kidney function, blood pressure, and stomach health.
  • Adherence: For some patients, delaying or missing a dose of indomethacin can cause the pain to return quickly, making the trial seem less successful [5]. Always follow your doctor’s or pharmacist’s instructions for a missed dose—never take an extra dose to make up for a missed one.
  • Evaluating All Symptoms: Hemicrania continua is formally characterized by a strictly one-sided headache present for more than three months without pain-free periods, featuring both a continuous background ache and superimposed severe flares [6][7]. These flares are typically accompanied by ipsilateral (same-side) autonomic symptoms, such as eye watering, nasal congestion, or restlessness [6]. Your doctor needs to know if the medication relieved the constant background pain, the flares, or both.

Do not increase your indomethacin dose on your own. Indomethacin carries risks of severe gastrointestinal injury (such as bleeding ulcers), blood pressure changes, kidney injury, and cardiovascular events [8][9]. It can interact dangerously with other NSAIDs, blood thinners, and blood pressure medications. Watch for symptoms requiring prompt care, such as black or bloody stools, vomiting blood, chest pain, severe shortness of breath, or markedly reduced urine output.

Reconsidering the Diagnosis

If a closely monitored trial of indomethacin provides only partial relief, it is time to consider other potential causes:

  • Other Primary Headaches: Migraines, cluster headaches, or other conditions in the trigeminal autonomic cephalalgia (TAC) family (a group of headaches often involving one-sided eye or nose symptoms) share similar features but respond differently to medications [7][10].
  • Secondary Causes: Sometimes, a structural issue, a vascular problem, or a pituitary lesion can mimic the symptoms [11][12]. A secondary condition might even partially or fully respond to indomethacin. Neuroimaging (such as a brain MRI) is commonly considered for this type of headache presentation. Depending on your clinical history and physical examination, your doctor may include specific sequences, such as pituitary views or vascular imaging, to evaluate for these mimics [13][11].

Other Treatment Options

If a full response cannot be safely achieved, or if indomethacin is not safe for you, your specialist may discuss other clinician-guided, often off-label options. These are not necessarily “safer,” and their success or failure does not establish or rule out hemicrania continua, but they may offer symptom control:

  • Other Medications: Options might include selective COX-2 inhibitors (like celecoxib, which may lower some stomach risks but still carries cardiovascular and kidney risks), topiramate, gabapentin, or melatonin [14][15].
  • Procedures and Devices: Targeted nerve blocks, onabotulinumtoxinA (Botox) injections, or non-invasive vagus nerve stimulation (a device that stimulates a nerve in the neck) are supported mainly by small studies and case reports [16][17][18].

Common questions in this guide

Can partial relief from indomethacin confirm hemicrania continua?
No. Formal diagnostic criteria generally require complete disappearance of the headache during an adequate therapeutic indomethacin trial, so partial relief neither confirms nor completely rules out hemicrania continua. A clinician must review how the trial was conducted and reconsider other causes.
Why might indomethacin help only part of my headache?
The dose and treatment length needed to test hemicrania continua vary by person, and missed or delayed doses can allow pain to return. The medicine may improve the constant background ache, the severe flares, or both to different degrees. Partial improvement can also reflect general pain relief rather than a diagnosis.
Is it safe to take more indomethacin if my pain continues?
Do not increase or double the dose without medical guidance. Indomethacin can cause stomach bleeding or ulcers, kidney injury, blood pressure changes, and cardiovascular problems, and it can interact with other medicines. Ask your prescriber or pharmacist what to do about ongoing pain or a missed dose.
What conditions can look like hemicrania continua when indomethacin only partly works?
Migraine, cluster headache, and other one-sided headache disorders can resemble hemicrania continua. Structural or vascular problems and pituitary lesions can also produce similar symptoms. Depending on your examination and history, a clinician may consider brain MRI and sometimes pituitary or blood-vessel imaging.
What treatments might be considered if indomethacin is not enough or is unsafe?
A headache specialist may discuss clinician-guided options such as a selective COX-2 inhibitor, topiramate, gabapentin, or melatonin. Targeted nerve blocks, Botox injections, or non-invasive vagus nerve stimulation may also be considered, but evidence is limited and these treatments may be off-label. Their success or failure does not by itself prove or exclude hemicrania continua.
When does a headache or indomethacin side effect need urgent care?
Seek emergency care for a sudden worst-ever headache, new weakness, confusion, vision loss, a painful red eye, fever with neck stiffness, or a headache after a head injury. While taking indomethacin, urgent symptoms also include black or bloody stools, vomiting blood, chest pain, severe shortness of breath, or markedly reduced urine output.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Hemicrania continua.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my trial of indomethacin involve an appropriate dose and duration to properly test for hemicrania continua, given my health history?
  2. 2.Based on my partial response, should we consider alternative diagnoses like migraine, cluster headache, or a secondary cause?
  3. 3.What specific type of brain imaging (such as an MRI with pituitary or vascular views) is appropriate to rule out other causes for my symptoms?
  4. 4.What is your monitoring plan for my blood pressure, kidney function, and stomach health while taking these medications?
  5. 5.Are there off-label treatment options we should consider if we cannot safely increase the indomethacin dose?

References

References (18)
  1. 1

    Hemicrania Continua: An Update.

    Al-Khazali HM, Christensen RH, Lambru G, et al.

    Current pain and headache reports 2023; (27(10)):543-550 doi:10.1007/s11916-023-01156-9.

    PMID: 37566220
  2. 2

    Do paroxysmal hemicrania and hemicrania continua represent different headaches? A retrospective study.

    Paliwal VK, Uniyal R, Aneez A, Singh LS

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(11)):2371-2376 doi:10.1007/s10072-019-03980-7.

    PMID: 31256266
  3. 3

    Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.

    Bordini EC, Bordini CA, Woldeamanuel YW, Rapoport AM

    Headache 2016; (56(2)):422-35 doi:10.1111/head.12771.

    PMID: 26853085
  4. 4

    Hemicrania continua secondary to neurogenic paravertebral tumor- a case report.

    Kalladka M, Al-Azzawi O, Heir GM, et al.

    Scandinavian journal of pain 2022; (22(1)):204-209 doi:10.1515/sjpain-2021-0089.

    PMID: 34432971
  5. 5

    Hemicrania Continua: An Update.

    Prakash S, Rawat KS

    Neurology India 2021; (69(Supplement)):S160-S167 doi:10.4103/0028-3886.315976.

    PMID: 34003161
  6. 6

    Hemicrania Continua.

    Prakash S, Adroja B

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S23-S30 doi:10.4103/aian.AIAN_352_17.

    PMID: 29720815
  7. 7

    Hemicrania continua: clinical review, diagnosis and management.

    Prakash S, Patel P

    Journal of pain research 2017; (10()):1493-1509 doi:10.2147/JPR.S128472.

    PMID: 28721092
  8. 8

    How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?

    Osiowski A, Stolarz K, Taterra D

    Current opinion in neurology 2025; (38(3)):254-261 doi:10.1097/WCO.0000000000001347.

    PMID: 39911098
  9. 9

    Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders.

    Farag M, Bahra A

    Headache 2022; (62(3)):383-388 doi:10.1111/head.14282.

    PMID: 35277974
  10. 10

    Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management.

    Wei DY, Yuan Ong JJ, Goadsby PJ

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S39-S44 doi:10.4103/aian.AIAN_348_17.

    PMID: 29720817
  11. 11

    The critical role of neuroimaging in hemicrania continua: A systematic review and case series.

    Yildiz Goksel H, Bilgin S, Digre K, et al.

    Headache 2024; (64(6)):674-684 doi:10.1111/head.14728.

    PMID: 38780233
  12. 12

    Hemicrania continua in carotid artery dissection - symptomatic cases or linked pathophysiology?

    Brilla R, Pawlowski M, Evers S

    Cephalalgia : an international journal of headache 2018; (38(2)):402-405 doi:10.1177/0333102416686346.

    PMID: 28056533
  13. 13

    Indomethacin-Responsive Headache Disorders.

    Goadsby PJ

    Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.

    PMID: 38568495
  14. 14

    Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

    Baraldi C, Pellesi L, Guerzoni S, et al.

    The journal of headache and pain 2017; (18(1)):71 doi:10.1186/s10194-017-0777-3.

    PMID: 28730562
  15. 15

    Melatonin in hemicrania continua and paroxysmal hemicrania.

    Cheung SN, Oliveira R, Goadsby PJ

    Cephalalgia : an international journal of headache 2024; (44(3)):3331024231226196 doi:10.1177/03331024231226196.

    PMID: 38518183
  16. 16

    OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients.

    Miller S, Correia F, Lagrata S, Matharu MS

    The journal of headache and pain 2015; (16()):19 doi:10.1186/s10194-015-0502-z.

    PMID: 25902798
  17. 17

    Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experience.

    Trimboli M, Al-Kaisy A, Andreou AP, et al.

    Cephalalgia : an international journal of headache 2018; (38(7)):1276-1285 doi:10.1177/0333102417731349.

    PMID: 28899205
  18. 18

    Treatment of hemicrania continua with radiofrequency ablation and long-term follow-up.

    Beams JL, Kline MT, Rozen TD

    Cephalalgia : an international journal of headache 2015; (35(13)):1208-13 doi:10.1177/0333102415575726.

    PMID: 25720768

This page is for informational purposes only and does not constitute medical advice. A qualified clinician should interpret your indomethacin response, assess medication risks, and evaluate any emergency symptoms.